Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Long-term survival after breast cancer diagnosis

02.06.2003


Most breast cancer patients with more than 10 nodes that are affected by the cancer have a poor prognosis, yet some survive long-term. Physicians now believe that certain genes in the breast cancer tissue, removed at diagnosis, can help them predict which patients will survive.



With this information, doctors can recommend the most appropriate therapy for an individual patient, for example sparing a woman with a poor prognosis the rigors that accompany aggressive chemotherapy, and enabling her to receive novel treatments that might work, according to Dr. Melody Cobleigh, oncologist, professor of medicine and director of the Comprehensive Breast Center at Rush-Presbyterian-St. Luke’s Medical Center in Chicago.

Cobleigh presented her research results on May 31 at the American Society of Clinical Oncology Annual Meeting in Chicago. Until now, such studies could only be performed on recently biopsied tissue that would then be frozen for preservation. Routine handling of cancer specimens does not involve freezing. Cobleigh and colleagues at Genomic Health examined the breast cancer tissue of 79 patients who had been treated at Rush between 1979 and 1999 and whose tissues had been processed in the usual manner (formalin-fixed and paraffin-embedded). The patients had been followed for a median of 15 years.


Expression of 185 cancer-related genes was assessed. The genes chosen were based on previous reports on frozen tissues. Cobleigh determined that those women whose tumors expressed excess amounts of some genes, e.g. TP53BP2, PR and Bcl2, were more likely to be free of cancer in their vital organs. She also found that women whose tumors expressed too much of other genes, e.g. GRB7, CTSL and DIABLO experienced a worse outcome. Cobleigh reported that even among women with 10 or more positive nodes, the gene expression profile could predict long-term survival.

"Until now, the only indications we have had of long-term prognosis were tumor size and the number of involved nodes," Cobleigh said. "This technology will allow us to tailor a prognosis to the individual patient, using information from thousands of genes."

She cautioned, however, that her research is a first step. "These findings must be confirmed in independent data sets," she said. She pointed out, however, that this is already underway, using material from tumor banks owned and managed by international cooperative groups, such as the National Surgical Adjuvant Breast and Bowel Project (NSABP), which is a clinical trials cooperative group supported by the National Cancer Institute (NCI). If results are validated, the test could become commercially available within a year.

Cobleigh, who was an investigator in the 1990s on the clinical trials to test the monoclonal antibody Herceptin, suggested that another offshoot of this work is to examine the tumor for expression of genes that will predict responsiveness to specific therapies, such as Herceptin.

Tumor tissue for this research was generated from the Bill Shorey Database of Breast Tumors, named after Dr. Bill Shorey, a breast surgeon who worked at Rush for more than 30 years. The Shorey Database was computerized by Dr. David Roseman, another surgeon who worked at Rush for over 30 years, and Michigan physician Dr. Craig Silverton.


Rush-Presbyterian-St. Luke’s Medical Center includes the 824-bed Presbyterian-St. Luke’s Hospital; 110-bed Johnston R. Bowman Health Center; Rush University (Rush Medical College, College of Nursing, College of Health Sciences and the Graduate College).

Chris Martin | EurekAlert!
Further information:
http://www.rush.edu/

More articles from Health and Medicine:

nachricht Investigators may unlock mystery of how staph cells dodge the body's immune system
22.09.2017 | Cedars-Sinai Medical Center

nachricht Monitoring the heart's mitochondria to predict cardiac arrest?
21.09.2017 | Boston Children's Hospital

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: The pyrenoid is a carbon-fixing liquid droplet

Plants and algae use the enzyme Rubisco to fix carbon dioxide, removing it from the atmosphere and converting it into biomass. Algae have figured out a way to increase the efficiency of carbon fixation. They gather most of their Rubisco into a ball-shaped microcompartment called the pyrenoid, which they flood with a high local concentration of carbon dioxide. A team of scientists at Princeton University, the Carnegie Institution for Science, Stanford University and the Max Plank Institute of Biochemistry have unravelled the mysteries of how the pyrenoid is assembled. These insights can help to engineer crops that remove more carbon dioxide from the atmosphere while producing more food.

A warming planet

Im Focus: Highly precise wiring in the Cerebral Cortex

Our brains house extremely complex neuronal circuits, whose detailed structures are still largely unknown. This is especially true for the so-called cerebral cortex of mammals, where among other things vision, thoughts or spatial orientation are being computed. Here the rules by which nerve cells are connected to each other are only partly understood. A team of scientists around Moritz Helmstaedter at the Frankfiurt Max Planck Institute for Brain Research and Helene Schmidt (Humboldt University in Berlin) have now discovered a surprisingly precise nerve cell connectivity pattern in the part of the cerebral cortex that is responsible for orienting the individual animal or human in space.

The researchers report online in Nature (Schmidt et al., 2017. Axonal synapse sorting in medial entorhinal cortex, DOI: 10.1038/nature24005) that synapses in...

Im Focus: Tiny lasers from a gallery of whispers

New technique promises tunable laser devices

Whispering gallery mode (WGM) resonators are used to make tiny micro-lasers, sensors, switches, routers and other devices. These tiny structures rely on a...

Im Focus: Ultrafast snapshots of relaxing electrons in solids

Using ultrafast flashes of laser and x-ray radiation, scientists at the Max Planck Institute of Quantum Optics (Garching, Germany) took snapshots of the briefest electron motion inside a solid material to date. The electron motion lasted only 750 billionths of the billionth of a second before it fainted, setting a new record of human capability to capture ultrafast processes inside solids!

When x-rays shine onto solid materials or large molecules, an electron is pushed away from its original place near the nucleus of the atom, leaving a hole...

Im Focus: Quantum Sensors Decipher Magnetic Ordering in a New Semiconducting Material

For the first time, physicists have successfully imaged spiral magnetic ordering in a multiferroic material. These materials are considered highly promising candidates for future data storage media. The researchers were able to prove their findings using unique quantum sensors that were developed at Basel University and that can analyze electromagnetic fields on the nanometer scale. The results – obtained by scientists from the University of Basel’s Department of Physics, the Swiss Nanoscience Institute, the University of Montpellier and several laboratories from University Paris-Saclay – were recently published in the journal Nature.

Multiferroics are materials that simultaneously react to electric and magnetic fields. These two properties are rarely found together, and their combined...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

“Lasers in Composites Symposium” in Aachen – from Science to Application

19.09.2017 | Event News

I-ESA 2018 – Call for Papers

12.09.2017 | Event News

EMBO at Basel Life, a new conference on current and emerging life science research

06.09.2017 | Event News

 
Latest News

Rainbow colors reveal cell history: Uncovering β-cell heterogeneity

22.09.2017 | Life Sciences

Penn first in world to treat patient with new radiation technology

22.09.2017 | Medical Engineering

Calculating quietness

22.09.2017 | Physics and Astronomy

VideoLinks
B2B-VideoLinks
More VideoLinks >>>